Page 133 - 《中国药房》2023年5期

pressing Th17 expansion[J]. Chem Eng J，2022，431： [30] SEDLAK T W，SALEH M，HIGGINSON D S，et al. Bili‐
133956. rubin and glutathione have complementary antioxidant
[18] KEUM H，KIM T W，KIM Y，et al. Bilirubin nanomedi‐ and cytoprotective roles[J]. Proc Natl Acad Sci U S A，
cine alleviates psoriatic skin inflammation by reducing 2009，106（13）：5171-5176.
oxidative stress and suppressing pathogenic signaling[J]. J [31] MAISELS M J，MCDONAGH A F. Phototherapy for neo‐
Control Release，2020，325：359-369. natal jaundice[J]. N Engl J Med，2008，358（9）：920-928.
[19] KAMOTHI D J，KANT V，JANGIR B L，et al. Novel [32] LEE Y，LEE S，LEE D Y，et al. Multistimuli-responsive
preparation of bilirubin-encapsulated pluronic F-127 bilirubin nanoparticles for anticancer therapy[J]. Angew
nanoparticles as a potential biomaterial for wound healing Chem Int Ed Engl，2016，55（36）：10676-10680.
[J]. Eur J Pharmacol，2022，919：174809. [33] LEE Y，LEE S，JON S. Biotinylated bilirubin nanopar‐
[20] KIM T W，KIM Y，JUNG W，et al. Bilirubin nanomedi‐ ticles as a tumor microenvironment-responsive drug deli-
cine ameliorates the progression of experimental autoim‐ very system for targeted cancer therapy[J]. Adv Sci
mune encephalomyelitis by modulating dendritic cells[J]. （Weinh），2018，5（6）：1800017.
J Control Release，2021，331：74-84. [34] YU M N，SU D Y，YANG Y Y，et al. D-T7 peptide-
[21] KIM D E，LEE Y，KIM M，et al. Bilirubin nanoparticles modified PEGylated bilirubin nanoparticles loaded with
ameliorate allergic lung inflammation in a mouse model cediranib and paclitaxel for antiangiogenesis and chemo‐
of asthma[J]. Biomaterials，2017，140：37-44. therapy of glioma[J]. ACS Appl Mater Interfaces，2019，11
[22] ZHAO X，HUANG C Y，SU M L，et al. Reactive oxygen （1）：176-186.
species-responsive celastrol-loaded：bilirubin nanopar‐ [35] SRIVASTAVA P，PALADHI A，SINGH R，et al. Targeting
ticles for the treatment of rheumatoid arthritis[J]. AAPS J， PD-1 in CD8 T cells with a biomimetic bilirubin-5-fluoro-
+
2021，24（1）：14. 2-deoxyuridine-bovine serum albumin nanoconstruct for
[23] YAO Q，JIANG X，ZHAI Y Y，et al. Protective effects and effective chemotherapy against experimental lymphoma
mechanisms of bilirubin nanomedicine against acute pan‐ [J]. Mol Pharm，2021，18（5）：2053-2065.
creatitis[J]. J Control Release，2020，322：312-325. [36] SHAN L L，FAN W P，WANG W W，et al. Organosilica-
[24] YAO Q，HUANG Z W，ZHAI Y Y，et al. Localized con‐ based hollow mesoporous bilirubin nanoparticles for
trolled release of bilirubin from β-cyclodextrin-conjugated antioxidation-activated self-protection and tumor-specific
ε -polylysine to attenuate oxidative stress and inflamma‐ deoxygenation-driven synergistic therapy[J]. ACS Nano，
tion in transplanted islets[J]. ACS Appl Mater Interfaces， 2019，13（8）：8903-8916.
2020，12（5）：5462-5475. [37] LEE D Y，KIM J Y，LEE Y，et al. Black pigment gallstone
[25] KEUM H，KIM D，KIM J，et al. A bilirubin-derived nano‐ inspired platinum-chelated bilirubin nanoparticles for com‐
medicine attenuates the pathological cascade of pulmo‐ bined photoacoustic imaging and photothermal therapy of
nary fibrosis[J]. Biomaterials，2021，275：120986. cancers[J]. Angew Chem Int Ed Engl，2017，56（44）：
[26] YANG Q Y，ZHOU C H，ZHAO Q，et al. Sonochemical 13684-13688.
assisted synthesis of dual functional BSA nanoparticle for [38] SRIVASTAVA P，HIRA S K，SRIVASTAVA D N，et al.
the removal of excessive bilirubin and strong anti-tumor Protease-responsive targeted delivery of doxorubicin from
effects[J]. Mater Sci Eng C Mater Biol Appl，2019，100： bilirubin-BSA-capped mesoporous silica nanoparticles
688-696. against colon cancer[J]. ACS Biomater Sci Eng，2017，3
[27] PETELIN A，JURDANA M，JENKO PRAŽNIKAR Z，et （12）：3376-3385.
al. Serum bilirubin correlates with serum adipokines in [39] LEE S，LEE Y，KIM H，et al. Bilirubin nanoparticle-
normal weight and overweight asymptomatic adults[J]. assisted delivery of a small molecule-drug conjugate for
Acta Clin Croat，2020，59（1）：19-29. targeted cancer therapy[J]. Biomacromolecules，2018，19
[28] DAINICHI T，KITOH A，OTSUKA A，et al. The epithe‐ （6）：2270-2277.
lial immune microenvironment （EIME） in atopic dermati‐ [40] JAYANTI S，MORETTI R，TIRIBELLI C，et al. Bilirubin：
tis and psoriasis[J]. Nat Immunol，2018，19（12）：1286- a promising therapy for Parkinson’s disease[J]. Int J Mol
1298. Sci，2021，22（12）：6223.
[29] KHAN N M，PODUVAL T B. Immunomodulatory and im‐ （收稿日期：2022-08-31 修回日期：2023-02-03）
munotoxic effects of bilirubin：molecular mechanisms[J]. （编辑：胡晓霖）
J Leukoc Biol，2011，90（5）：997-1015.

中国药房 2023年第34卷第5期 China Pharmacy 2023 Vol. 34 No. 5 · 635 ·